Ozempic, Wegovy on list for Medicare drug price negotiations

Obesity drugs Ozempic and Wegovy included in US price-cut talks

Novo Nordisk shares hit as government adds blockbuster weight-loss treatments to new round of negotiations

Financial Times - 1h

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.

CNBC - 6h

Ozempic Among the Next Drugs Up for Medicare Price Negotiations

The list of drugs account for $41 billion in annual Medicare spending, the Biden administration said.

The Wall Street Journal - 7h

Medicare to Negotiate Lower Prices for Weight-Loss Drugs

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.

The New York Times - 9h

Negotiators Reach Cease-Fire and Hostage Deal for Gaza

The agreement, which must still be approved by the Israeli cabinet, incited joy in the Gaza Strip and Israel, even as some feared that it could fall apart.

The New York Times - 1d

Biden to Commute Drug Offender Sentences

The action, aimed at inmates who received harsher sentences based on old disparities in drug laws, is the broadest commutation of individual sentences ever issued by a U.S. president.

The New York Times - 2h

Biden pardons nearly 2,500 nonviolent drug offenders

"With this action, I have now issued more individual pardons and commutations than any president in U.S. history," President Joe Biden wrote in his announcement Friday.

ABC News - 7h

The next 15 drugs chosen for Medicare negotiation

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts before the inauguration of President-elect Trump. The Centers for Medicare ...

The Hill - 8h

White House says popular weight-loss drug Ozempic subject to Medicare talks

Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.

MarketWatch - 8h

Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.

NBC News - 8h

CMS to seek Medicare negotiations on Ozempic price

The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide ...

The Hill - 9h

Biden administration picks 15 more drugs for Medicare negotiation

The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule. Administration officials did ...

The Hill - 10h

How Ozempic Has Forever Changed How Much People Spend on Food, According to a New Cornell University Study

Ozempic doesn’t just reduce weight. Research shows GLP-1s also changes how much people spend on food, and the types of food they buy.

Inc. - 1d

Medicare's new $2,000 cap on out-of-pocket drug costs could save patients thousands, AARP says

The AARP report suggests the spending cap could be huge for Medicare enrollees who take costly drugs for cancer, rheumatoid arthritis, and other conditions.

CNBC - 1d

Breaking down Trump's involvement in ceasefire negotiations

Along with President Biden's Middle East envoy, President-elect Donald Trump's incoming administration was involved in Israel-Hamas ceasefire negotiations. Margaret Brennan has analysis.

CBS News - 1d

Top 3 drug insurers reaped billions as their drug middlemen inflated prices, FTC alleges

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from ‘excess’ prescription price hikes of 1,000% or more.

NBC News - 3d

The King of Ozempic Is Scared as Hell

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Wired - 4d

This Rule Helps You Never Negotiate Against Yourself

How to maintain your leverage during negotiations.

Inc. - 5d

Baby boomers and ‘Ozempic face’ drive injectables craze

People ‘want to look what they feel like, not what they may look like’ says dermatology giant Galderma

Financial Times - 5d

Regulators Tell Baltimore Drug Program to ‘Cease and Desist’

Maryland issued the order after an investigation by The New York Times and The Baltimore Banner traced overdoses and deaths to an addiction program offering free housing.

The New York Times - 6d

Corrective action is needed to preserve Social Security, Medicare and Medicaid

Any lasting fiscal reforms must moderate the growth of the largest mandatory spending programs: Social Security, Medicare and Medicaid.

The Hill - Jan. 10

Inside the UK's first legal drug consumption room

The Thistle will open its doors next week after nearly a decade of deadlock over drug laws.

BBC News - Jan. 10

Prices of top 25 Medicare Part D drugs have nearly doubled, AARP study finds

AARP's new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing Medicare to negotiate prices.

CNBC - Jan. 9

How Trump’s Greenland Plan Could Hit Ozempic, Legos and Hearing Aids

Putting tariffs on Denmark unless it cedes the island of Greenland could hurt access to a few key products, including popular medicines.

The New York Times - Jan. 9

Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.

NBC News - Jan. 9

Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact

At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss ...

MarketWatch - Jan. 8

Johnson says no cuts to Social Security and Medicare to fund Trump's agenda

House Speaker Mike Johnson said cuts to Social Security and Medicare won't be part of the legislative plan being worked out to fund President-elect Donald Trump's agenda.

ABC News - Jan. 7

Louisiana mayor arrested after drug trafficking investigation

Seven people — including Tyrin Truong, mayor of Bogalusa, Louisiana — are facing charges issued in connection with a drug trafficking investigation.

CBS News - Jan. 7

Ketamine could be reclassified as Class A drug

Illegal use of the drug reached record levels last year, the Home Office said.

BBC News - Jan. 7

Golden Globes Winners: The Full List

The winning films, TV shows, actors and production teams at the 2025 Golden Globe Awards.

The New York Times - Jan. 6

Golden Globes 2025: Winners list

The winners of the 82nd Golden Globe Awards will be revealed Sunday. Follow along here for live updates on who comes out on top.

Los Angeles Times - Jan. 6

Congestion pricing is a New York idea.

A Columbia University economist, William Vickrey, proposed charging varying tolls for roads and subways in the 1950s.

The New York Times - Jan. 5

N.Y.C. Congestion Pricing Begins on Sunday

After twists and turns, a contentious plan meant to reduce traffic and pay for transit improvements is scheduled to take effect at midnight Sunday.

The New York Times - Jan. 4

What’s going to happen with Social Security and Medicare in 2025?

What retirees should know about these important benefits heading into the new year.

MarketWatch - Jan. 4

In France, Drug Traffic Spreads to Small Towns

Even quaint corners of the country are seeing a rise in drug violence and crime. Just ask the mayor of Morlaix, which has a population of about 15,000.

The New York Times - Jan. 4

Why Coffee Prices Are Soaring (Again)

Wholesale coffee prices are trading near a 50-year high because of shortages related to extreme weather and increased global demand.

The New York Times - Jan. 4

Here's what to know about Medicare's new spending cap

This year, a new spending cap on medication goes into effect for the first time for people on Medicare. CBS News medical contributor Dr. Celine Gounder explains its impact.

CBS News - Jan. 2

Ozempic, Wegovy on list for Medicare drug price negotiations

Topics